We are live on !
Find out more
Exane Derivatives Portfolio holdings
AUM
$174M
Turnover
34.02%
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$181M
(-51%)
Cap. Flow
-$142M
Cap. Flow % of AUM
Cap. Flow %
-81.48%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
1,070
New
55
Increased
89
Reduced
355
Closed
309
Avg Time Held
Equity + Options
2.5
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.5
years
Avg Time Held Equity only
2.5
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$4.55M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$3.23M |
| 3 |
Dow Inc
DOW
|
+$1.28M |
| 4 |
Conagra Brands
CAG
|
+$1.04M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$952K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.98M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.74M |
| 3 |
Visa
V
|
+$4.62M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$4.31M |
| 5 |
Stellantis
STLA
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.4% |
| 2 | Technology | 15.03% |
| 3 | Healthcare | 12.1% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
iShares MSCI EAFE Value ETF
EFV
$30.6B
| $260 | ﹤0.01% |
6
| – | – |
2021 Q1
5 quarters
|
|
652
DBV Technologies S.A. American Depositary Shares
DBVT
$596M
| $258 | ﹤0.01% |
10
| – | – |
2020 Q1
9 quarters
|
|
653
Pan American Silver
PAAS
$15.7B
| $256 | ﹤0.01% |
13
-246
| -95% | -$5.9K |
2020 Q2
8 quarters
|
|
654
iShares MSCI Philippines ETF
EPHE
$141M
| $254 | ﹤0.01% |
10
| – | – |
2016 Q4
22 quarters
|
|
655
Sol-Gel Technologies
SLGL
$224M
| $250 | ﹤0.01% |
6
| – | – |
2021 Q2
4 quarters
|
|
656
Minerals Technologies
MTX
$1.95B
| $245 | ﹤0.01% |
4
| – | – |
2021 Q2
4 quarters
|
|
657
Neogen
NEOG
$2.58B
| $241 | ﹤0.01% |
10
-2,831
| -100% | -$76K |
2020 Q4
6 quarters
|
|
658
Extreme Networks
EXTR
$2.99B
| $232 | ﹤0.01% |
26
| – | – |
2021 Q2
4 quarters
|
|
659
Easterly Government Properties
DEA
$1.06B
| $228 | ﹤0.01% |
5
-83
| -94% | -$4.04K |
2020 Q2
8 quarters
|
|
660
T. Rowe Price
TROW
$22.2B
| $227 | ﹤0.01% |
2
| – | – |
2021 Q4
2 quarters
|
|
661
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $226 | ﹤0.01% |
5
| – | – |
2017 Q4
18 quarters
|
|
662
Sarepta Therapeutics
SRPT
$1.97B
| $225 | ﹤0.01% |
3
-43
| -93% | -$3.16K |
2018 Q2
16 quarters
|
|
663
Iovance Biotherapeutics
IOVA
$3.84B
| $221 | ﹤0.01% |
20
| – | – |
2019 Q2
12 quarters
|
|
664
Enterprise Products Partners
EPD
$82.4B
| $219 | ﹤0.01% |
9
| – | – |
2014 Q4
30 quarters
|
|
665
Global X Lithium & Battery Tech ETF
LIT
$1.22B
| $218 | ﹤0.01% |
3
| – | – |
2019 Q2
12 quarters
|
|
666
Primoris Services
PRIM
$3.92B
| $218 | ﹤0.01% |
10
| – | – |
2021 Q2
4 quarters
|
|
667
Nu Skin
NUS
$226M
| $216 | ﹤0.01% |
5
| – | – |
2019 Q2
12 quarters
|
|
668
Royal Gold
RGLD
$19.4B
| $214 | ﹤0.01% |
2
| – | – |
2017 Q2
20 quarters
|
|
669
PTC
PTC
$21.2B
| $213 | ﹤0.01% |
2
| – | – |
2017 Q4
18 quarters
|
|
670
NovoCure
NVCR
$1.54B
| $208 | ﹤0.01% |
3
-786
| -100% | -$59.2K |
2020 Q4
6 quarters
|
|
|
ADAP
671
DELISTED
Adaptimmune Therapeutics
ADAP
| $206 | ﹤0.01% |
121
| – | – |
2018 Q1
17 quarters
|
|
672
iShares Russell 2000 Growth ETF
IWO
$13.8B
| $206 | ﹤0.01% |
1
| – | – |
2017 Q4
18 quarters
|
|
673
CME Group
CME
$109B
| $205 | ﹤0.01% |
+1
| New | +$212 |
2022 Q2
0 quarters
|
|
674
DELISTED
DigitalBridge
DBRG
| $205 | ﹤0.01% |
+11
| New | +$268 |
2022 Q2
0 quarters
|
|
675
Biogen
BIIB
$37.5B
| $204 | ﹤0.01% |
1
| – | – |
2014 Q4
30 quarters
|
|
Similar funds
GDWAM
Exane Derivatives's Q2 2022 Portfolio in Review
As of Q2 2022, Exane Derivatives held 1,070 positions worth $174M, down 51% from $355M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Exane Derivatives withdrew a net $142M in Q2 2022, closing 309 positions and reducing 355 holdings. Its most notable exit was Amazon, an estimated $5.98M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Exane Derivatives opened a new position in iShares Core US Aggregate Bond ETF worth $4.5M.
- Exane Derivatives's largest Q2 2022 buy was iShares Core US Aggregate Bond ETF: 44,298 shares worth $4.5M.
- Exane Derivatives added most to Dow Inc in Q2 2022, an estimated $1.28M increase.
- Exane Derivatives's biggest Q2 2022 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $4.74M.
- Exane Derivatives fully exited Amazon in Q2 2022, selling an estimated $5.98M.
- Exane Derivatives's ten largest holdings make up 28% of its $174M portfolio in Q2 2022.
- Exane Derivatives opened 55 new positions and closed 309 in Q2 2022.
- Exane Derivatives's portfolio value fell 51% quarter-over-quarter to $174M.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.